Rivulet Media, Inc. Sample Contracts

EQUITY PURCHASE AGREEMENT BY AND BETWEEN BIO-MATRIX SCIENTIFIC GROUP, INC. AND SOUTHRIDGE PARTNERS II, LP Dated April 23, 2012
Equity Purchase Agreement • May 8th, 2012 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • New York

THIS EQUITY PURCHASE AGREEMENT entered into as of the 23st day of April, 2012 (this "AGREEMENT"), by and between SOUTHRIDGE PARTNERS II, LP, Delaware limited partnership ("INVESTOR"), and BIO-MATRIX SCIENTIFIC GROUP, INC., a Delaware corporation (the "COMPANY").

AutoNDA by SimpleDocs
Contract
Unit Purchase Agreement • December 27th, 2016 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

THIS UNIT PURCHASE AGREEMENT (the “Agreement”) is entered into by and among Regen Biopharma, Inc., a Nevada corporation (the “Company”) whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and __________( “Purchaser”), a _______ whose address is _____________.

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • May 8th, 2012 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • New York

This Registration Rights Agreement ("Agreement"), dated April 23, 2012, is made by and between BIO-MATRIX SCIENTIFIC GROUP, INC. a Delaware corporation ("Company"), and SOUTHRIDGE PARTNERS II, LP, a Delaware limited partnership (the "Investor").

RIVULET MEDIA, INC. STOCK OPTION AGREEMENT
Stock Option Agreement • November 12th, 2020 • Rivulet Media, Inc. • Services-business services, nec • Delaware

Rivulet Media, Inc. has granted to the individual (the “Participant”) named in the Notice of Grant of Stock Option (the “Notice”) to which this Stock Option Agreement (the “Option Agreement”) is attached an option (the “Option”) to purchase certain shares of Common Stock upon the terms and conditions set forth in the Notice and this Option Agreement. The Option has been granted pursuant to and shall in all respects be subject to the terms and conditions of the Rivulet Media, Inc. 2020 Equity Incentive Plan (the “Plan”), as amended to the Date of Option Grant, the provisions of which are incorporated herein by reference. By signing the Notice, the Participant: (a) represents that the Participant has received copies of, and has read and is familiar with the terms and conditions of, the Notice, the Plan, and this Option Agreement, (b) accepts the Option subject to all of the terms and conditions of the Notice, the Plan, and this Option Agreement, and (c) agrees to accept as binding, concl

EMPLOYMENT AGREEMENT BETWEEN REGEN BIOPHARMA, INC AND CHRISTINE ICHIM
Employment Agreement • January 22nd, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of January 14, 2015 is entered into between Regen BioPharma, Inc., a Nevada corporation, (the "Company") and Christine Ichim ("Employee").

AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC.
License Agreement • June 26th, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

THIS LICENSE AGREEMENT, including the exhibits referred to herein and attached hereto (the “Agreement”), effective as of June 23, 2015 (the “Effective Date”), is made and entered into by and between Regen BioPharma Inc., an Nevada corporation (“Licensor”) and Zander Therapeutics Inc., a Nevada corporation (“Licensee”). Licensor and Licensee may be referred to in this Agreement each as a “Party” or collectively as the “Parties.”

UNIT PURCHASE AGREEMENT REGEN BIOPHARMA, INC.
Unit Purchase Agreement • November 24th, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

THIS UNIT PURCHASE AGREEMENT (the “Agreement”) is entered into by and among Regen Biopharma, Inc., a Nevada corporation (the “Company”) whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and __________( “Purchaser”), a _______ whose address is _____________.

EMPLOYMENT AGREEMENT BETWEEN REGEN BIOPHARMA, INC. AND TODD S. CAVEN
Employment Agreement • February 13th, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of February 11, 2015 is entered into between Regen BioPharma, Inc., a Nevada corporation, (the "Company") and Todd S. Caven ("Employee").

AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND SANTOSH KESARI
Consulting Agreement • August 11th, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

Agreement by and between Santosh Kesari (“Consultant”) , a natural person whose address is at 3525 Del Mar Heights Road #133, San Diego CA 92130 and Regen Biopharma, Inc. (“Company”) , a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942.

SUBLEASE AGREEMENT
Sublease Agreement • December 29th, 2014 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec

This is an agreement to sublet office space located at 4700 Spring Street, Suite 304, La Mesa, California 91942 according to the terms specified below.

PROMISSORY NOTE
Promissory Note • January 31st, 2022 • Rivulet Media, Inc. • Services-business services, nec • Arizona

FOR VALUE RECEIVED, RIVULET MEDIA, INC., a Delaware corporation with an address of 1206 E. Warner Rd, Suite 101-I, Gilbert, AZ 85296 (“Maker”), agrees and promises to pay to the order of ____________________ (“Holder”) or his designee, the sum of ____________________ ($__________).

EMPLOYMENT AGREEMENT BETWEEN REGEN BIOPHARMA, INC. AND
Employment Agreement • October 13th, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of October 9, 2015 is entered into between Regen BioPharma, Inc., a Nevada corporation, (the "Company") and Harry M. Lander ("Employee").

SUBSCRIPTION AGREEMENT RIVULET MEDIA, INC.
Subscription Agreement • October 22nd, 2020 • Rivulet Media, Inc. • Services-business services, nec • Arizona

The undersigned (“Purchaser”) hereby subscribes to purchase the amount of Series A convertible promissory notes (“Notes”) of Rivulet Media, Inc., a Delaware corporation (the “Company”), set forth on the signature page hereof, with a minimum investment of $25,000. The Notes are convertible into shares of common stock of the Company (“Shares”) at the option of the Purchaser at a conversion price of $0.80 per Share and, should the closing price of the Shares as reflected on the OTC Market reach $1.20 or higher, shall automatically convert into the number of Shares that results by dividing the outstanding principal amount and all accrued but unpaid interest by $0.80. This subscription may be rejected by the Company in its sole discretion.

EMPLOYMENT AGREEMENT BETWEEN
Employment Agreement • June 28th, 2012 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of June 15, 2012 is entered into between Bio-Matrix Scientific Group, Inc., a Delaware corporation, (the "Company") and Thomas Ichim ("Employee").

AMENDMENT TO LICENSE AGREEMENT DATED APRIL 6, 2015
License Agreement • August 26th, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec

Benitec Australia Limited, an Australian corporation (ACN 080 299 645) having its registered office at 1-15 Barr Street, Balmain, NSW, Australia 2041, (“Benitec Australia”) and Regen BioPharma, Inc., a United States company having its registered office at 4700 Spring Street, Suite 304, La Mesa, CA 91942 USA, (“Regen BioPharma”)entered into a license agreement ( the “Agreement”) on August 5, 2013. Benitec Australia and Regen BioPharma may be referred to in this Agreement each as a “Party” or collectively as the “Parties.”

LICENSE AGREEMENT - EXECUTION
License Agreement • August 6th, 2013 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • New South Wales

THIS LICENSE AGREEMENT, including the exhibits referred to herein and attached hereto (the “Agreement”), effective as of August 5, 2013 (the “Effective Date”), is made and entered into by and between Benitec Australia Limited, an Australian corporation (ACN 080 299 645) having its registered office at 1-15 Barr Street, Balmain, NSW, Australia 2041, (“Benitec Australia”) and Regen BioPharma, Inc., a United States company having its registered office at 4700 Spring Street, Suite 304, La Mesa, CA 91942 USA, (“Regen BioPharma”). Benitec Australia and Regen BioPharma may be referred to in this Agreement each as a “Party” or collectively as the “Parties.”

SERVICE AGREEMENT
Independent Contractor Agreement • October 1st, 2013 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

This Independent Contractor Agreement (“Agreement”) is entered into this 27th day of July 2013 between Dr. Wei Ping Min (“Min”), a research scientist (hereinafter referred to as “Contractor”) whose address is 84 Hesketh Street, London Ontario N6G5H5, Canada and Regen BioPharma, Inc. (hereinafter referred to as “Client”), a Nevada corporation with offices at 4700 Spring Street, Suite 304, La Mesa, CA 91942.

EMPLOYMENT AGREEMENT
Employment Agreement • August 17th, 2020 • Rivulet Media, Inc. • Services-business services, nec • Arizona

This EMPLOYMENT AGREEMENT (“Agreement”) is made in the State of Arizona by and between Michael J. Witherill (“Executive”) and Rivulet Media, Inc., a Delaware corporation (the “Company”).

July 1, 2016 David Koos Chairman & CEO Regen BioPharma Inc. (RGBP) La Mesa, CA 91942 Delivered: 07/01/2016 Via email to: David Koos david.koos@regenbiopharma.com Dear David,
Investment Banking Engagement Agreement • July 7th, 2016 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec

The purpose of this investment banking engagement agreement (the "Agreement") is to set forth the terms and conditions pursuant to which CIM Securities, LLC ("CIM"), a FINRA member in good standing, shall act as exclusive financial advisor and placement agent for Regen BioPharma Inc. (RGBP, RGBPP) (“Company”), a Nevada Corporation and all affiliates (also the "Company") and introduce the Company to one or more accredited investors (“Investors”) in connection to a proposed private placement (the "Private Placement") of equity and / or debt securities (the "Securities") of the Company for the capital needed to continue research and development on four blocker compounds. However, CIM specifically acknowledges that the Company has retained Objective Capital Partners, located in San Diego, California, to identify potential strategic partners for the Company, which could result in an infusion of capital that does not involve the sale of debt or equity securities. The gross proceeds from the

EMPLOYMENT AGREEMENT BETWEEN ENTEST BIOMEDICAL, INC. AND DR. GREGORY MCDONALD, DVM
Employment Agreement • January 11th, 2011 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of December 31, 2010 is entered into between Entest BioMedical, Inc., a California corporation, (the "Company") and Dr. Gregory McDonald ("Employee").

AutoNDA by SimpleDocs
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND THOMAS ICHIM
Consulting Agreement • November 5th, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

Agreement made on November 2. 2015 by and between Thomas Ichim (“Consultant”) , a natural person whose address is at 9255 Towne Centre Drive #450 San Diego CA 91211 and Regen Biopharma, Inc. (“Company”) , a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942. Consultant and Company may be referred to individually as “Party” and collectively as “Parties”.

Contract
Collaboration Agreement • August 25th, 2009 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec

AGREEMENT made this 18th day of August, 2009, by and between Therinject LLC, whose principal place of business is 10439 Roselle St Ste E hereinafter referred to as "Therinject", Steven Josephs, whose address is 1129 Rising Hill Way, Escondido, CA 92029 hereinafter referred to as “Josephs” and Bio-Matrix Scientific Group, Inc., whose principal place of business is 8885 Rehco Road, San Diego, California 92121, hereinafter referred to as "Company". Collectively, the Company, Therinject and Josephs may be referred to as the “Parties” or, singularly as “Party”

Exclusive License Agreement Between OHSU and Regen BioPharma, INC For Invention Disclosure 0472
Exclusive License Agreement • June 12th, 2013 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • Oregon

This Exclusive License Agreement (this "Agreement"), dated and effective as of June 5, 2013 (the "Effective Date"), is between the Oregon Health & Science University, having offices at 0690 SW Bancroft Street, L106TT, Portland, Oregon 97239 ("OHSU"), and Regen BioPharma, Inc., having offices at 4700 Spring St # 304, La Mesa, CA 91942 ("Licensee"). OHSU and Licensee are herein referred to each as a "Party" and collectively as the "Parties."

Agreement made this 5th day of August 2016 by and between Regen Bioparma, Inc. (“Company) and David R. Koos (“Koos”)
Employment Agreement • December 27th, 2016 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

WHEREAS, On February 13, 2015 Koos was issued Nine Million of the Company’s Common Shares (“Compensation Common Shares”) pursuant to that employment agreement entered into by and between Koos and the Company on February 11, 2015 ( “Employment Agreement”)

Consulting Agreement
Consulting Agreement • December 29th, 2014 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

Agreement by and between Christine Ichim (“Consultant”) , a natural person whose address is at 12685 Campo Road, Spring Valley CA 91978 and Regen Biopharma, Inc. (“Company”) , a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942.

STOCK PURCHASE AGREEMENT
Stock Purchase Agreement • June 22nd, 2009 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

THIS STOCK PURCHASE AGREEMENT (the “Agreement”) is entered into and is effective on this 16th day of June 2009 by and between JB Clothing Corporation, a Nevada corporation with principal address at 47 Fountainhead Circle, Henderson, Nevada 89052 (the “Buyer”), and Bio-Matrix Scientific Group, Inc., a Delaware corporation with principal address at 8885 Rehco Road, San Diego, California 92121 (the “Seller”). As used in this Agreement, the term, “Parties” shall refer to the Buyer and the Seller jointly.

SPECIAL ESCROW AGREEMENT
Special Escrow Agreement • June 15th, 2006 • Tasco Holdings International, Inc. • Services-business services, nec • California

This Special Escrow Agreement (the "Escrow Agreement") is entered into as of June 9, 2006 by and between William M. Aul (the "Escrow Agent"), Bio-Matrix Scientific Group, Inc., a Delaware corporation (the “Seller”) and John Lauring (the “Stockholder”) herein collectively referred to herein as the “Parties” (“Parties”).

ASSET PURCHASE AGREEMENT
Asset Purchase Agreement • January 11th, 2011 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec

This Asset Purchase Agreement ("AGREEMENT") is made as of December 17, 2010 by and among ENTEST BIOMEDICAL, INC., a California corporation (“Buyer”) which is wholly owned by ENTEST BIOMEDICAL INC., A Nevada corporation publicly traded on the OTC Bulletin Board under the symbol ENTB, PET POINTERS, INC., a California corporation ("Seller") doing business as McDonald Animal Hospital and DR. GREGORY MCDONALD, the sole shareholder, officer and director of the Seller (“Dr. Gregory McDonald” or “McDonald”).

Marketing Services Agreement
Marketing Services Agreement • August 8th, 2007 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec

This Marketing Services Agreement (the “Agreement”) is entered into and is effective this 23 day of August 2005 by and between Bio-Matrix Scientific Group, Inc., a Delaware corporation with principal offices at 1010 University Avenue, Suite 40, San Diego, California 92108 (the “Company”), and Cord Blood America, Inc., a Florida corporation with principal offices at 9000 Sunset Boulevard, Suite 400, Los Angeles, California 90069 (“Marketer”). The term “Parties,” as used in this Agreement, shall jointly refer to the Company and Marketer.

Date: August 11, 2008
Letter of Intent • August 19th, 2008 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec

This letter confirms our understanding of the mutual present intentions of Bio-Matrix Scientific Group, Inc. ("BMSN") and Cord Blood America ("CBAI") with respect to the principal terms and conditions under which BMSN shall provide storage and processing services to CBAI ("Transactions").

CONSULTING AGREEMENT
Consulting Agreement • April 30th, 2009 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

THIS CONSULTING AGREEMENT ("Agreement") is made this 8th day of April, 2009, by and between Brian Koos, whose address is 27-139 CHS, 10833 Le Conte Avenue, Los Angeles, CA 90025-1740, hereinafter referred to as "CONSULTANT", and Bio-Matrix Scientific Group, Inc. , whose principal place of business is 8885 Rehco Road, San Diego, California 92121, hereinafter referred to as "Company".

WARRANT TO PURCHASE COMMON STOCK
Warrant to Purchase Common Stock • August 28th, 2012 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California

THIS CERTIFIES THAT, for value received, Caven Investments, LLC, a Minnesota limited liability company or permitted assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from Bio-Matrix Scientific Group, Inc., a Nevada corporation (the “Company”), up to sixteen million, five hundred thousand (16,500,000) shares of the Common Stock of the Company (the “Exercise Stock”).

SUBSCRIPTION AGREEMENT RIVULET MEDIA, INC.
Subscription Agreement • January 4th, 2021 • Rivulet Media, Inc. • Services-business services, nec • Arizona

The undersigned (the “Purchaser”) hereby subscribes to purchase the number of shares of Common Stock, $0.0001 par value per share, of Rivulet Media, Inc., a Delaware corporation (the “Company”), set forth on the signature page hereof at a cash purchase price of $0.10 per share. The shares being purchased are referred to herein as the “Shares.” This subscription may be rejected by the Company in its sole discretion.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!